National and regional funding landscape for medical devices and in-vitro diagnostics in Europe
- The focus on many medical device companies is on establishing reimbursement, which is mechanism of payment for technology. However, once mechanism is place the very critical element of funding by payers shall be addressed. In this webinar we will review funding landscape for medical devices and in-vitro diagnostic tests in key European markets
- The following topics will be discussed:
- Relationship between reimbursement and funding
- Mapping of countries with funding framework for medical devices
- Key features of landmark funding frameworks:
- National commissioning by NHS England and local commissioning by Clinical Commissioning Groups
- “New methods” framework in Norway
- Priority setting councils and national managed introduction framework in Sweden
- G-BA process, selective contracting in Germany
- Reviews of the Federal Commission for Medical Benefits and Principles (ELGK) in Switzerland
- Webinar will be conducted by CEO, Mattias Kyhlstedt and Director of Health Economics and Market Access, Oleg Borisenko
- Please, fill in the form below to register for the webinar. Note, that representatives of consulting companies are not allowed to register.